Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs (original) (raw)

Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C

Victor Marquez

Journal of medicinal chemistry, 1996

View PDFchevron_right

Structural analogies between protein kinase C activators

Véronique Cabiaux

Biochemical and Biophysical Research Communications, 1985

View PDFchevron_right

Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity

Gerhardt Wagner

Cancer research, 1998

View PDFchevron_right

The Transition from a Pharmacophore-Guided Approach to a Receptor-Guided Approach in the Design of Potent Protein Kinase C Ligands

Kassoum Nacro

Pharmacology & Therapeutics, 1999

View PDFchevron_right

Rapid screening method for inhibitors of protein kinase C

Hiroyuki Osada

The Journal of Antibiotics, 1988

View PDFchevron_right

Conformationally constrained analogs of diacylglycerol. Interaction of .gamma.-lactones with the phorbol ester receptor of protein kinase C

Victor Marquez

Journal of the American Chemical Society, 1992

View PDFchevron_right

Partial down-regulation of protein kinase C reverses the growth inhibitory effect of phorbol esters on HepG2 cells

Brian Huber

Journal of Cellular Physiology, 1990

View PDFchevron_right

Differential Localization of Protein Kinase C delta by Phorbol Esters and Related Compounds Using a Fusion Protein with Green Fluorescent Protein

nobuteru usuda

Journal of Biological Chemistry, 1999

View PDFchevron_right

Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C

Konrad Koehler

Proceedings of the National Academy of Sciences, 1988

View PDFchevron_right

Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C

Narsimha mamidi

Molecular BioSystems, 2012

View PDFchevron_right

Activation of the PKC-isotypes α, β1, γ, δ, and ε by phorbol esters of different biological activities

Peter Parker

FEBS Letters, 1991

View PDFchevron_right

A comparative study of the effect of the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-glycero-3-phosphocholine and some homologous compounds on PKCα and PKCɛ

Pablo Conesa Zamora

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005

View PDFchevron_right

Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells

Romano Regazzi

Biochemical and Biophysical Research Communications, 1986

View PDFchevron_right

Phorbol ester binding and protein kinase C activity in normal and transformed human keratinocytes

Gerry Snoek

Experimental Cell Research, 1987

View PDFchevron_right

Discovery of 4-Benzylamino-Substituted α-Carbolines as a Novel Class of Receptor Tyrosine Kinase Inhibitors

Martin Krug

ChemMedChem, 2011

View PDFchevron_right

A new tumor promoter from the seed oil of Jatropha curcas L. an intramolecular diester of 12-deoxy-16-hydroxy phorbol. Cancer Res 8:5800-5804

Maitree S Suttajit

Cancer Research

View PDFchevron_right

UNIVERSITÀ DEGLI STUDI DI PAVIA SYNTHESIS OF NOVEL PROTEIN KINASE C C1 DOMAIN TARGETED COMPOUNDS

NUNZIA CRISTIANO

View PDFchevron_right

Differential Localization of Protein Kinase C δ by Phorbol Esters and Related Compounds Using a Fusion Protein with Green Fluorescent Protein

Kassoum Nacro

Journal of Biological Chemistry, 1999

View PDFchevron_right

The complete primary structure of protein kinase C--the major phorbol ester receptor

Peter Parker

Science, 1986

View PDFchevron_right

A new inhibitor of protein kinase C, RK-1409B (4'-demethylamino-4'-hydroxy-3'-epistaurosporine)

Hiroyuki Osada

The Journal of Antibiotics, 1992

View PDFchevron_right

Rationally designed peptide regulators of protein kinase C

Eric Churchill

Trends in Endocrinology & Metabolism, 2009

View PDFchevron_right

Structural investigation of protein kinase C inhibitors

Dov Barak

Journal of Molecular Structure-theochem, 1991

View PDFchevron_right

Inhibition of phorbol ester-receptor binding by a factor from human serum

Kimball Woodward

Molecular and Cellular Biology, 1982

View PDFchevron_right

Phorbol ester and 1,2‐diolein are not fully equivalent activators of protein kinase C in respect to phosphorylation of membrane proteins in vitro

Zoltan Kiss

FEBS Letters, 1986

View PDFchevron_right

Structural Basis of Protein Kinase C Activation by Tumor Promoters

Maria Angeles A Pajares

Accounts of Chemical Research, 1998

View PDFchevron_right

Evaluation of (2S,4S)/(2R,4R) and (2S,4R)/(2R,4S) 6,6-N,N-dimethyl-2-methyl-2-oxo-1,3-dioxa-4-hexadecyl-6,aza-2-phosphacyclooctane bromide as inhibitors for protein kinase C, carnitine octanoyltransferase, and carnitine palmitoyltransferase

Rona Ramsay

Bioorganic & Medicinal Chemistry Letters, 1994

View PDFchevron_right

Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cells

Gayle Woloschak

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989

View PDFchevron_right

Second stage tumor promoters: Differences in biological potency and phorbol ester receptor affinity in C6 cells

joseph BRESSLER

Cancer Letters, 1987

View PDFchevron_right

Phorbol Esters Mediate Phospholipid-free Activation of Rat Brain Protein Kinase C1

Isabelle Martelly

Cancer Research, 1990

View PDFchevron_right

4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors

Ramaswamy Nilakantan

Journal of Medicinal Chemistry, 2000

View PDFchevron_right

A new tumor promoter from the seed oil of Jatropha curcas L., an intramolecular diester of 12-deoxy-16-hydroxyphorbol

Maitree S Suttajit

Cancer Research, 1988

View PDFchevron_right

Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods

Mahboubeh Mansourian

Research in Pharmaceutical Sciences

View PDFchevron_right

Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics

Søren Christensen

ACS Medicinal Chemistry Letters, 2019

View PDFchevron_right

Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation

Marole Maluleka

View PDFchevron_right

Phorbol esters induce multidrug resistance in human breast cancer cells

JAY PATEL

Proceedings of the National Academy of Sciences, 1988

View PDFchevron_right